BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15250025)

  • 1. Antimicrobial prophylaxis in febrile neutropenia.
    Yoshida M; Ohno R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S65-7. PubMed ID: 15250025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia.
    Schrøder H; Agger KE; Rosthøj S; Carlsen NT; Schmiegelow K
    Dan Med Bull; 2001 Nov; 48(4):275-7. PubMed ID: 11767129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary.
    Masaoka T
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S49-52. PubMed ID: 15250021
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trimethoprim-sulfamethoxazole as antibacterial prophylaxis during induction therapy of children with acute lymphatic leukemia].
    Agger KE; Schrøder H; Rosthøj S; Carlsen NT; Schmiegelow K
    Ugeskr Laeger; 2002 Jan; 164(4):488-92. PubMed ID: 11838420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey.
    Yoshida M; Ohno R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S11-4. PubMed ID: 15250015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.
    Ramphal R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S25-31. PubMed ID: 15250017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients.
    Viscoli C; Paesmans M; Sanz M; Castagnola E; Klastersky J; Martino P; Glauser M;
    Clin Infect Dis; 2001 Jun; 32(11):1532-7. PubMed ID: 11340522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical antifungal therapy in treating febrile neutropenic patients.
    Wingard JR
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S38-43. PubMed ID: 15250019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments.
    Rolston KV
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S44-8. PubMed ID: 15250020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
    Gomez L; Garau J; Estrada C; Marquez M; Dalmau D; Xercavins M; Martí JM; Estany C
    Cancer; 2003 Jan; 97(2):419-24. PubMed ID: 12518366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of patients with hematologic neoplasm, fever, and neutropenia.
    Sepkowitz KA
    Clin Infect Dis; 2005 Apr; 40 Suppl 4():S253-6. PubMed ID: 15768331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the febrile neutropenic patient: a consensus conference.
    Picazo JJ
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S1-6. PubMed ID: 15250013
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of fever in neutropenic patients with different risks of complications.
    Klastersky J
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S32-7. PubMed ID: 15250018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological data for patients with febrile neutropenia.
    Kanamaru A; Tatsumi Y
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S7-S10. PubMed ID: 15250014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.
    Krupova I; Kaiserova E; Foltinova A; Kovacicova G; Kiskova M; Krchnakova A; Kunova A; Trupl J; West D; Krcmery V
    J Chemother; 1998 Jun; 10(3):236-42. PubMed ID: 9669650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of systemic mycoses in patients who are not neutropenic: should we do it? Can we do it?
    Graybill JR
    Braz J Infect Dis; 2000 Jun; 4(3):108-12. PubMed ID: 10934492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
    Leibovici L; Paul M; Cullen M; Bucaneve G; Gafter-Gvili A; Fraser A; Kern WV
    Cancer; 2006 Oct; 107(8):1743-51. PubMed ID: 16977651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.